DMSO and Cancer

DMSO is a Miraculous Therapy for Chronic Pain and Musculoskeletal Injuries

By A Midwestern Doctor

The article begins by critiquing the standard medical approach to chronic pain and musculoskeletal injuries, which relies heavily on nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and, in severe cases, opioids. These treatments, while common, carry significant risks: NSAIDs contribute to tens of thousands of deaths annually from gastrointestinal bleeding and cardiovascular issues, and opioids are a leading cause of drug-related hospital admissions due to addiction and overdose. In contrast, DMSO is presented as a safer, more effective alternative that has been unjustly overlooked despite decades of evidence supporting its efficacy.

History of DMSO Use

DMSO, a byproduct of the wood industry, was initially explored in the 1960s by Dr. Stanley Jacob, who discovered its ability to penetrate skin and alleviate pain. Early experiments showed it could relieve conditions like sprains, arthritis, and burns with remarkable speed—often instantly—and without the toxicity of conventional drugs. Its versatility stems from multiple mechanisms: it reduces inflammation, improves blood flow, relaxes muscles, protects cells from death, and blocks pain signals. These properties make it uniquely suited to treat a wide range of conditions, from acute injuries to chronic pain syndromes, with an 80-90% success rate reported in various studies and anecdotal accounts.

The article details DMSO’s historical rise and fall. By the mid-1960s, it had gained widespread popularity, with hundreds of thousands of Americans using it for conditions like arthritis and sports injuries. Professional athletes, in particular, embraced it for rapid recovery. Over 1,000 studies confirmed its benefits, including its ability to heal wounds, reduce scarring, and treat complex regional pain syndrome (CRPS)—a notoriously difficult condition. Testimonies from patients, such as quadriplegics regaining movement or individuals overcoming decades of debilitating pain, underscore its potential to transform lives. For instance, a mother recounted her paralyzed child regaining mobility after DMSO treatment, a result replicated in numerous cases where improvement ceased when DMSO was discontinued.

The FDA enters the arena

Despite this, the FDA halted DMSO’s momentum in 1965 after reports of lens changes in animal studies (later disproven in humans), banning all research except for interstitial cystitis, its only approved use today. The article argues this decision was politically motivated, driven by pharmaceutical interests threatened by DMSO’s low cost and non-patentable nature. Congressional hearings in 1980-1982, featuring thousands of supportive testimonies, failed to sway the FDA, which the author accuses of prioritizing profit over patient welfare. This suppression, the article contends, has cost millions the chance to avoid disability or death from conditions DMSO could treat.

Using DMSO

The author provides practical guidance on using DMSO, emphasizing its safety when properly handled. It’s typically applied topically at 50-90% concentration, often diluted with water to avoid skin irritation (a common side effect, along with a garlic-like breath odor). For musculoskeletal issues, a 70% solution is recommended, applied sparingly to clean skin over the affected area, with effects often noticeable within minutes. The article advises starting with small doses, avoiding contaminated sources (e.g., industrial-grade DMSO), and consulting knowledgeable practitioners due to its limited mainstream acceptance. Success stories from readers—such as a woman whose 10-year back pain vanished in 30 minutes—reinforce its efficacy.

DMSO’s broader implications are also explored. Beyond pain and injuries, it has shown promise in treating strokes, spinal cord injuries, autoimmune disorders, and even cancer, enhancing chemotherapy while mitigating its side effects. The author laments that these applications remain underutilized due to the FDA’s stance, contrasting DMSO’s safety profile (no documented deaths) with the lethal risks of NSAIDs and opioids. The article suggests that DMSO’s ability to address root causes like inflammation and poor circulation explains its wide-ranging benefits, surpassing the symptom-focused approach of conventional drugs.

Conclusion

In conclusion, the article portrays DMSO as a “miracle drug” buried by a medical establishment beholden to profit-driven agendas. It calls for renewed interest, supported by grassroots demand and emerging practitioner adoption (e.g., Dr. Pierre Kory’s recent focus on DMSO). The author encourages readers to explore DMSO responsibly, citing trusted sources like dmso.store, and reflects on its potential to revolutionize medicine if freed from regulatory shackles. This narrative blends scientific evidence, historical critique, and personal testimonies to argue that DMSO’s sidelining is a profound loss to human health, urging a reevaluation of its place in modern therapy.